Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2
Description
COVID-19 has stimulated the rapid development of new antibody and small molecule therapeutics to inhibit SARS-CoV-2 infection. Here we describe a third antiviral modality that combines the drug-like advantages of both. Bicycles are entropically
